Please Wait
Applying Filters...
menu
    • menu
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Varegacestat

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Immunome Presents Phase 3 RINGSIDE Data for Varegacestat
    Immunome Presents Phase 3 RINGSIDE Data for Varegacestat

    30 May 2026

    // PRESS RELEASE

    https://investors.immunome.com/immunome-announces-detailed-phase-3-ringside-data-for-varegacestat-in-adults-with-progressing-desmoid-tumors-at-the-2026-asco-annual-meeting/

    PRESS RELEASE
    30 May 2026
    Share Share
    Immunome Files FDA NDA for Varegacestat in Desmoid Tumors
    Immunome Files FDA NDA for Varegacestat in Desmoid Tumors

    29 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260429083050/en/Immunome-Announces-Submission-of-New-Drug-Application-to-U.S.-FDA-for-Varegacestat-for-the-Treatment-of-Adults-with-Desmoid-Tumors

    BUSINESSWIRE
    29 Apr 2026
    Share Share
    Immunome Presents Phase 3 RINGSIDE Data At 2026 ASCO Meeting
    Immunome Presents Phase 3 RINGSIDE Data At 2026 ASCO Meeting

    21 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-21/immunome-announces-oral-presentation-of-phase-3-ringside-data-at-2026-asco-annual-meeting-1

    PHARMIWEB
    21 Apr 2026
    Share Share
    Immunome Unveils 2025 Financials And Business Update
    Immunome Unveils 2025 Financials And Business Update

    03 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260303337450/en/Immunome-Reports-Full-Year-2025-Financial-Results-and-Provides-Business-Update

    BUSINESSWIRE
    03 Mar 2026
    Share Share
    Immunome's Experimental Drug Meets Main Goal in Study
    Immunome's Experimental Drug Meets Main Goal in Study

    15 Dec 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/immunomes-experimental-drug-meets-main-goal-late-stage-study-2025-12-15/

    REUTERS
    15 Dec 2025
    Share Share
    Immunome Unveils Q3 2025 Financials & Business Update
    Immunome Unveils Q3 2025 Financials & Business Update

    06 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251106467522/en/Immunome-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update

    BUSINESSWIRE
    06 Nov 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.